Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.
Antibody specific for viral neuraminidase can be demonstrated in mice following (i) pulmonary infection with influenza virus, (ii) immunization with ultraviolet-in-activated influenza virus, (iii) immunization with isolated neuraminidase of influenza A(2) virus, and (iv) passive immunization with sera of rabbits immunized with isolated A(2) neuraminidase. Neuraminidase antibody produced by any of these methods exerts a profound inhibiting effect on virus replication in the lungs of mice challenged with strains of virus having homologous neuraminidase protein, even in the absence of hemagglutinating inhibiting antibody to the challenge virus, and results in markedly decreased pulmonary virus titers and diminished lung lesions. These observations suggest that antineuraminidase immunity may play a significant role in the protection against influenza virus challenge observed in mice after infection or artificial immunization.
D000336:Aerosols; D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D003588:Cytopathogenic Effect, Viral; D006385:Hemagglutination Inhibition Tests; D006389:Hemagglutinins, Viral; D007112:Immunity, Maternally-Acquired; D007267:Injections; D008171:Lung Diseases / Q000473:pathology; D051379:Mice; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D009975:Orthomyxoviridae / Q000528:radiation effects; D009976:Orthomyxoviridae Infections / Q000276:immunology*; D011830:Radiation Effects; D013053:Spectrophotometry; D014466:Ultraviolet Rays
D000336:Aerosols; D000941:Antigens; D006389:Hemagglutinins, Viral; D009439:Neuraminidase